{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:20:12Z","timestamp":1782793212432,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/50\/45"],"award-info":[{"award-number":["RGP2\/50\/45"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"DOI":"10.1186\/s13568-024-01731-2","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T18:02:29Z","timestamp":1722621749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Vinpocetine and Lactobacillus improve fatty liver in rats: role of adiponectin and gut microbiome"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-6907","authenticated-orcid":false,"given":"Ahmed M.","family":"El-Baz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal A.","family":"Nouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Negm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attalla F.","family":"El-kott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"AlShehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"4","key":"1731_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","volume":"20","author":"CC Allain","year":"1974","unstructured":"Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20(4):470\u2013475","journal-title":"Clin Chem"},{"issue":"2","key":"1731_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/hep.23365","volume":"51","author":"ZM Bamboat","year":"2010","unstructured":"Bamboat ZM, Balachandran VP, Ocuin LM, Obaid H, Plitas G, DeMatteo RP (2010) Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51(2):621\u2013632. https:\/\/doi.org\/10.1002\/hep.23365","journal-title":"Hepatology"},{"issue":"12","key":"1731_CR3","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1021\/ac60205a053","volume":"35","author":"I Bergman","year":"1963","unstructured":"Bergman I, Loxley R (1963) Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 35(12):1961\u20131965. https:\/\/doi.org\/10.1021\/ac60205a053","journal-title":"Anal Chem"},{"issue":"6","key":"1731_CR4","doi-asserted-by":"publisher","first-page":"G1018","DOI":"10.1152\/ajpgi.00245.2016","volume":"311","author":"S Bluemel","year":"2016","unstructured":"Bluemel S, Williams B, Knight R, Schnabl B (2016) Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. Am J Physiol Gastrointest Liver Physiol 311(6):G1018\u2013g1036. https:\/\/doi.org\/10.1152\/ajpgi.00245.2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"1731_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.14218\/jcth.2018.00008","volume":"7","author":"L Campo","year":"2019","unstructured":"Campo L, Eiseler S, Apfel T, Pyrsopoulos N (2019) Fatty liver disease and gut microbiota: a comprehensive update. J Clin Transl Hepatol 7(1):56\u201360. https:\/\/doi.org\/10.14218\/jcth.2018.00008","journal-title":"J Clin Transl Hepatol"},{"key":"1731_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/foods10081719","author":"V Castillo","year":"2021","unstructured":"Castillo V, Figueroa F, Gonz\u00e1lez-Pizarro K, Jopia P, Ibacache-Quiroga C (2021) Probiotics and prebiotics as a strategy for non-alcoholic fatty liver disease, a narrative review. Foods https:\/\/doi.org\/10.3390\/foods10081719","journal-title":"Foods"},{"key":"1731_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/597134","author":"SS Chambel","year":"2015","unstructured":"Chambel SS, Santos-Goncalves A, Duarte TL (2015) The dual role of Nrf2 in nonalcoholic fatty liver disease: regulation of antioxidant defenses and hepatic lipid metabolism. Biomed Res Int https:\/\/doi.org\/10.1155\/2015\/597134","journal-title":"Biomed Res Int"},{"issue":"7","key":"1731_CR8","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/odi.13153","volume":"25","author":"LY Ding","year":"2019","unstructured":"Ding LY, Liang LZ, Zhao YX, Yang YN, Liu F, Ding QR, Luo LJ (2019) Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-\u03baB and JNK signaling pathways. Oral Dis 25(7):1789\u20131797. https:\/\/doi.org\/10.1111\/odi.13153","journal-title":"Oral Dis"},{"key":"1731_CR10","doi-asserted-by":"publisher","first-page":"117927","DOI":"10.1016\/j.lfs.2020.117927","volume":"256","author":"AM El-Baz","year":"2020","unstructured":"El-Baz AM, Khodir AE, Adel El-Sokkary MM, Shata A (2020) The protective effect of Lactobacillus versus 5-aminosalicylic acid in ulcerative colitis model by modulation of gut microbiota and Nrf2\/Ho-1 pathway. Life Sci 256:117927. https:\/\/doi.org\/10.1016\/j.lfs.2020.117927","journal-title":"Life Sci"},{"key":"1731_CR11","doi-asserted-by":"publisher","first-page":"107757","DOI":"10.1016\/j.intimp.2021.107757","volume":"96","author":"AM El-Baz","year":"2021","unstructured":"El-Baz AM, Shata A, Hassan HM, El-Sokkary MMA, Khodir AE (2021) The therapeutic role of lactobacillus and montelukast in combination with metformin in diabetes mellitus complications through modulation of gut microbiota and suppression of oxidative stress. Int Immunopharmacol 96:107757. https:\/\/doi.org\/10.1016\/j.intimp.2021.107757","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1731_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13568-023-01561-8","volume":"13","author":"AM El-Baz","year":"2023","unstructured":"El-Baz AM, El-Ganiny AM, Hellal D, Anwer HM, El-Aziz HAA, Tharwat IE, El-Adawy MA, Helal SEM, Mohamed MTA, Azb TM, Elshafaey HM, Shalata AA, Elmeligi SM, Abdelbary NH, El-Kott AF, Al-Saeed FA, Salem ET, El-Sokkary MMA, Shata A, Shabaan AA (2023) Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2\/HO-1 and gut microbiota. AMB Express 13(1):57. https:\/\/doi.org\/10.1186\/s13568-023-01561-8","journal-title":"AMB Express"},{"key":"1731_CR12","doi-asserted-by":"publisher","first-page":"113942","DOI":"10.1016\/j.bcp.2020.113942","volume":"177","author":"MO El-Derany","year":"2020","unstructured":"El-Derany MO, El-Demerdash E (2020) Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: insight on hedgehog\/Gli and Wnt\/\u03b2-catenin signaling crosstalk. Biochem Pharmacol 177:113942. https:\/\/doi.org\/10.1016\/j.bcp.2020.113942","journal-title":"Biochem Pharmacol"},{"key":"1731_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.lfs.2019.03.014","volume":"222","author":"RM Essam","year":"2019","unstructured":"Essam RM, Ahmed LA, Abdelsalam RM, El-Khatib AS (2019) Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: modulation of cAMP\/CREB\/TLR4 inflammatory and fibrogenic pathways. Life Sci 222:245\u2013254. https:\/\/doi.org\/10.1016\/j.lfs.2019.03.014","journal-title":"Life Sci"},{"issue":"4","key":"1731_CR14","first-page":"e17354","volume":"8","author":"AAI Fooladi","year":"2015","unstructured":"Fooladi AAI, Yazdi MH, Pourmand MR, Mirshafiey A, Hassan ZM, Azizi T, Mahdavi M, Dallal MMS (2015) Th1 cytokine production induced by Lactobacillus acidophilus in BALB\/c mice bearing transplanted breast tumor. Jundishapur J Microbiol 8(4):e17354","journal-title":"Jundishapur J Microbiol"},{"key":"1731_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3389\/fnins.2018.01027","volume":"12","author":"L Forny-Germano","year":"2018","unstructured":"Forny-Germano L, De Felice FG, Vieira M (2018) The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer\u2019s disease. Front Neurosci 12:1027. https:\/\/doi.org\/10.3389\/fnins.2018.01027","journal-title":"Front Neurosci"},{"issue":"10","key":"1731_CR16","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","volume":"28","author":"P Fossati","year":"1982","unstructured":"Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28(10):2077\u20132080","journal-title":"Clin Chem"},{"key":"1731_CR17","doi-asserted-by":"publisher","unstructured":"Galicia-Moreno M, Lucano-Landeros S, Monroy-Ramirez HC, Silva-Gomez J, Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J (2020) Roles of Nrf2 in Liver diseases: molecular, pharmacological, and epigenetic aspects. Antioxid (Basel Switzerland) 9(10):980 https:\/\/doi.org\/10.3390\/antiox9100980","DOI":"10.3390\/antiox9100980"},{"key":"1731_CR18","doi-asserted-by":"crossref","unstructured":"Garcia-Castillo V, Komatsu R, Clua P, Indo Y, Takagi M, Salva S, Islam MA, Alvarez S, Takahashi H, Garcia-Cancino A (2019) Evaluation of the immunomodulatory activities of the probiotic strain Lactobacillus fermentum UCO-979\u00a0C. Front Immunol 10:1376","DOI":"10.3389\/fimmu.2019.01376"},{"issue":"10","key":"1731_CR19","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1021\/tx9701790","volume":"11","author":"D G\u00e9rard-Monnier","year":"1998","unstructured":"G\u00e9rard-Monnier D, Erdelmeier I, R\u00e9gnard K, Moze-Henry N, Yadan J-C, Chaudi\u00e8re J (1998) Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 11(10):1176\u20131183. https:\/\/doi.org\/10.1021\/tx9701790","journal-title":"Chem Res Toxicol"},{"key":"1731_CR20","doi-asserted-by":"publisher","unstructured":"G\u00f3mez-Zorita S, Aguirre L, Milton-Laskibar I, Fern\u00e1ndez-Quintela A, Trepiana J, Kajarabille N, Mosqueda-Sol\u00eds A, Gonz\u00e1lez M, Portillo MP (2019) Relationship between changes in microbiota and liver steatosis induced by high-fat feeding-a review of rodent models. Nutrients https:\/\/doi.org\/10.3390\/nu11092156","DOI":"10.3390\/nu11092156"},{"issue":"3","key":"1731_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","volume":"52","author":"EL Guimaraes","year":"2010","unstructured":"Guimaraes EL, Empsen C, Geerts A, van Grunsven LA (2010) Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J Hepatol 52(3):389\u2013397 https:\/\/doi.org\/10.1016\/j.jhep.2009.12.007","journal-title":"J Hepatol"},{"issue":"6","key":"1731_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696\u2013699. https:\/\/doi.org\/10.1016\/0168-8278(95)80226-6","journal-title":"J Hepatol"},{"issue":"2","key":"1731_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/apt.15314","volume":"50","author":"S Jayakumar","year":"2019","unstructured":"Jayakumar S, Loomba R (2019) Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. Aliment Pharmacol Ther 50(2):144\u2013158. https:\/\/doi.org\/10.1111\/apt.15314","journal-title":"Aliment Pharmacol Ther"},{"key":"1731_CR24","doi-asserted-by":"publisher","first-page":"175172","DOI":"10.1016\/j.ejphar.2022.175172","volume":"931","author":"EM Khalaf","year":"2022","unstructured":"Khalaf EM, Hassan HM, El-Baz AM, Shata A, Khodir AE, Yousef ME, Elgharabawy RM, Nouh NA, Saleh S, Bin-Meferij MM, El-kott AF, El-Sokkary MMA, Eissa H (2022) A novel therapeutic combination of dapagliflozin, Lactobacillus and crocin attenuates diabetic cardiomyopathy in rats: role of oxidative stress, gut microbiota, and PPAR\u03b3 activation. Eur J Pharmacol 931:175172. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175172","journal-title":"Eur J Pharmacol"},{"key":"1731_CR25","doi-asserted-by":"publisher","unstructured":"Kim HN, Joo EJ, Cheong HS, Kim Y, Kim HL, Shin H, Chang Y, Ryu S (2019) Gut microbiota and risk of Persistent nonalcoholic fatty liver diseases. J Clin Med https:\/\/doi.org\/10.3390\/jcm8081089","DOI":"10.3390\/jcm8081089"},{"issue":"6","key":"1731_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/apt.15416","volume":"50","author":"N Koopman","year":"2019","unstructured":"Koopman N, Molinaro A, Nieuwdorp M, Holleboom AG (2019) Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease. Aliment Pharmacol Ther 50(6):628\u2013639. https:\/\/doi.org\/10.1111\/apt.15416","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1731_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3350\/cmh.2020.0125","volume":"27","author":"NY Lee","year":"2021","unstructured":"Lee NY, Shin MJ, Youn GS, Yoon SJ, Choi YR, Kim HS, Gupta H, Han SH, Kim BK, Lee DY, Park TS, Sung H, Kim BY, Suk KT (2021) Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis. Clin Mol Hepatol 27(1):110\u2013124. https:\/\/doi.org\/10.3350\/cmh.2020.0125","journal-title":"Clin Mol Hepatol"},{"issue":"5","key":"1731_CR28","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.24552","volume":"54","author":"L Li","year":"2011","unstructured":"Li L, Chen L, Hu L, Liu Y, Sun HY, Tang J, Hou YJ, Chang YX, Tu QQ, Feng GS, Shen F, Wu MC, Wang HY (2011) Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 54(5):1620\u20131630. https:\/\/doi.org\/10.1002\/hep.24552","journal-title":"Hepatology"},{"key":"1731_CR29","doi-asserted-by":"publisher","first-page":"733507","DOI":"10.3389\/fmolb.2021.733507","volume":"8","author":"X Li","year":"2021","unstructured":"Li X, Hong J, Wang Y, Pei M, Wang L, Gong Z (2021) Trimethylamine-N-Oxide pathway: a potential target for the treatment of MAFLD. Front Mol Biosci 8:733507. https:\/\/doi.org\/10.3389\/fmolb.2021.733507","journal-title":"Front Mol Biosci"},{"issue":"2","key":"1731_CR30","doi-asserted-by":"publisher","first-page":"2255825","DOI":"10.1080\/07853890.2023.2255825","volume":"55","author":"L Liu","year":"2023","unstructured":"Liu L, Geng Y, Xiong C (2023) Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease. Ann Med 55(2):2255825. https:\/\/doi.org\/10.1080\/07853890.2023.2255825","journal-title":"Ann Med"},{"issue":"2","key":"1731_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","volume":"68","author":"A Lonardo","year":"2018","unstructured":"Lonardo A, Nascimbeni F, Mantovani A, Targher G (2018) Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol 68(2):335\u2013352. https:\/\/doi.org\/10.1016\/j.jhep.2017.09.021","journal-title":"J Hepatol"},{"issue":"5","key":"1731_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/clinchem\/23.5.882","volume":"23","author":"MF Lopes-Virella","year":"1977","unstructured":"Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23(5):882\u2013884","journal-title":"Clin Chem"},{"issue":"5","key":"1731_CR33","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.3390\/ijms22052350","volume":"22","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Dalbeni A (2021) Treatments for NAFLD: state of art. Int J Mol Sci 22(5):2350. https:\/\/doi.org\/10.3390\/ijms22052350","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1731_CR34","doi-asserted-by":"publisher","first-page":"834","DOI":"10.15252\/msb.20156487","volume":"11","author":"A Mardinoglu","year":"2015","unstructured":"Mardinoglu A, Shoaie S, Bergentall M, Ghaffari P, Zhang C, Larsson E, B\u00e4ckhed F, Nielsen J (2015) The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol Syst Biol 11(10):834. https:\/\/doi.org\/10.15252\/msb.20156487","journal-title":"Mol Syst Biol"},{"issue":"3","key":"1731_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47(3):469\u2013474. https:\/\/doi.org\/10.1111\/j.1432-1033.1974.tb03714.x","journal-title":"Eur J Biochem"},{"issue":"Suppl 1","key":"1731_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000447275","volume":"34","author":"A Mazzotti","year":"2016","unstructured":"Mazzotti A, Caletti MT, Sasdelli AS, Brodosi L, Marchesini GJDD (2016) Pathophysiology of nonalcoholic fatty liver disease: lifestyle-gut-gene interaction. Dig Dis 34(Suppl 1):3\u201310","journal-title":"Dig Dis"},{"key":"1731_CR37","doi-asserted-by":"publisher","unstructured":"Mijangos-Trejo A, Nu\u00f1o-Lambarri N, Barbero-Becerra V, Uribe-Esquivel M, Vidal-Cevallos P, Ch\u00e1vez-Tapia N (2023) Prebiotics and Probiotics: therapeutic tools for nonalcoholic fatty liver disease. Int J Mol Sci https:\/\/doi.org\/10.3390\/ijms241914918","DOI":"10.3390\/ijms241914918"},{"issue":"1","key":"1731_CR38","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/niox.2000.0319","volume":"5","author":"KM Miranda","year":"2001","unstructured":"Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5(1):62\u201371. https:\/\/doi.org\/10.1006\/niox.2000.0319","journal-title":"Nitric Oxide"},{"issue":"1","key":"1731_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta (BBA) - Gen Subj 582(1):67\u201378. https:\/\/doi.org\/10.1016\/0304-4165(79)90289-7","journal-title":"Biochimica et Biophysica Acta (BBA) Gen Subj"},{"key":"1731_CR40","doi-asserted-by":"publisher","unstructured":"Petric Z, Paix\u00e3o P, Filipe A, Guimar\u00e3es Morais J (2023) Clinical pharmacology of Vinpocetine: Properties Revisited and introduction of a Population Pharmacokinetic Model for its Metabolite, Apovincaminic Acid (AVA). Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics15102502","DOI":"10.3390\/pharmaceutics15102502"},{"issue":"3","key":"1731_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/JCI34275","volume":"118","author":"C Postic","year":"2008","unstructured":"Postic C, Girard J (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118(3):829\u2013838. https:\/\/doi.org\/10.1172\/JCI34275","journal-title":"J Clin Invest"},{"key":"1731_CR42","doi-asserted-by":"publisher","unstructured":"Rom O, Liu Y, Liu Z, Zhao Y, Wu J, Ghrayeb A, Villacorta L, Fan Y, Chang L, Wang L, Liu C, Yang D, Song J, Rech JC, Guo Y, Wang H, Zhao G, Liang W, Koike Y, Lu H, Koike T, Hayek T, Pennathur S, Xi C, Wen B, Sun D, Garcia-Barrio MT, Aviram M, Gottlieb E, Mor I, Liu W, Zhang J, Chen YE (2020) Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome. Sci Transl Med https:\/\/doi.org\/10.1126\/scitranslmed.aaz2841","DOI":"10.1126\/scitranslmed.aaz2841"},{"issue":"5","key":"1731_CR43","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.cmet.2020.03.006","volume":"31","author":"BJ Saeedi","year":"2020","unstructured":"Saeedi BJ, Liu KH, Owens JA, Hunter-Chang S, Camacho MC, Eboka RU, Chandrasekharan B, Baker NF, Darby TM, Robinson BS, Jones RM, Jones DP, Neish AS (2020) Gut-resident Lactobacilli activate hepatic Nrf2 and protect against oxidative liver injury. Cell Metabol 31(5):956\u2013968e5. https:\/\/doi.org\/10.1016\/j.cmet.2020.03.006","journal-title":"Cell Metabol"},{"key":"1731_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fmicb.2018.00061","volume":"9","author":"ET Saltzman","year":"2018","unstructured":"Saltzman ET, Palacios T, Thomsen M, Vitetta L (2018) Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease. Front Microbiol 9:61","journal-title":"Front Microbiol"},{"key":"1731_CR45","doi-asserted-by":"publisher","first-page":"112789","DOI":"10.1016\/j.biopha.2022.112789","volume":"148","author":"ME Shaker","year":"2022","unstructured":"Shaker ME (2022) The contribution of sterile inflammation to the fatty liver disease and the potential therapies. Biomed Pharmacother 148:112789. https:\/\/doi.org\/10.1016\/j.biopha.2022.112789","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1731_CR46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","volume":"16","author":"F Shen","year":"2017","unstructured":"Shen F, Zheng R-D, Sun X-Q, Ding W-J, Wang X-Y, Fan J-G (2017) Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int 16(4):375\u2013381","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1731_CR47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","volume":"28","author":"GP Sims","year":"2010","unstructured":"Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ (2010) HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28:367\u2013388. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132603","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"1731_CR48","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.aohep.2019.11.010","volume":"19","author":"A Solano-Urrusquieta","year":"2020","unstructured":"Solano-Urrusquieta A, Morales-Gonz\u00e1lez JA, Castro-Narro GE, Cerda-Reyes E, Flores-Rangel PD, Fierros-Oceguera R (2020) NRF-2 and nonalcoholic fatty liver disease. Ann Hepatol 19(5):458\u2013465. https:\/\/doi.org\/10.1016\/j.aohep.2019.11.010","journal-title":"Ann Hepatol"},{"issue":"1","key":"1731_CR49","doi-asserted-by":"publisher","first-page":"e13646","DOI":"10.1111\/obr.13646","volume":"25","author":"X Su","year":"2024","unstructured":"Su X, Chen S, Liu J, Feng Y, Han E, Hao X, Liao M, Cai J, Zhang S, Niu J, He S, Huang S, Lo K, Zeng F (2024) Composition of gut microbiota and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Obes Reviews: Official J Int Association Study Obes 25(1):e13646. https:\/\/doi.org\/10.1111\/obr.13646","journal-title":"Obes Reviews: Official J Int Association Study Obes"},{"key":"1731_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cellsig.2018.06.005","volume":"49","author":"B Wahlang","year":"2018","unstructured":"Wahlang B, McClain C, Barve S, Gobejishvili L (2018) Role of cAMP and phosphodiesterase signaling in liver health and disease. Cell Signal 49:105\u2013115. https:\/\/doi.org\/10.1016\/j.cellsig.2018.06.005","journal-title":"Cell Signal"},{"key":"1731_CR51","doi-asserted-by":"publisher","first-page":"32002","DOI":"10.1038\/srep32002","volume":"6","author":"B Wang","year":"2016","unstructured":"Wang B, Jiang X, Cao M, Ge J, Bao Q, Tang L, Chen Y, Li L (2016) Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease. Sci Rep 6:32002. https:\/\/doi.org\/10.1038\/srep32002","journal-title":"Sci Rep"},{"issue":"8","key":"1731_CR52","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gutjnl-2016-312766","volume":"66","author":"SH Wong","year":"2017","unstructured":"Wong SH, Kwong TN, Chow T-C, Luk AK, Dai RZ, Nakatsu G, Lam TY, Zhang L, Wu JC, Chan FK (2017) Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut 66(8):1441\u20131448","journal-title":"Gut"},{"key":"1731_CR53","doi-asserted-by":"publisher","unstructured":"Yan L, Li Y, Tan T, Qi J, Fang J, Guo H, Ren Z, Gou L, Geng Y, Cui H, Shen L, Yu S, Wang Z, Zuo Z (2023) RAGE-TLR4 crosstalk is the key mechanism by which high glucose enhances the Lipopolysaccharide-Induced Inflammatory response in primary bovine alveolar macrophages. Int J Mol Sci https:\/\/doi.org\/10.3390\/ijms24087007","DOI":"10.3390\/ijms24087007"},{"issue":"9","key":"1731_CR54","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/apt.12046","volume":"36","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz Y (2012) Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther 36(9):815\u2013823. https:\/\/doi.org\/10.1111\/apt.12046","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1731_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2017.08.001","volume":"22","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Henry L, Bush H, Mishra A (2018) Clinical and economic burden of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis 22(1):1\u201310. https:\/\/doi.org\/10.1016\/j.cld.2017.08.001","journal-title":"Clin Liver Dis"},{"issue":"2","key":"1731_CR56","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.20045","volume":"39","author":"S Zeng","year":"2004","unstructured":"Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, Dun H, Lu Y, Qu W, Schmidt AM, Emond JC (2004) Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 39(2):422\u2013432. https:\/\/doi.org\/10.1002\/hep.20045","journal-title":"Hepatology"},{"key":"1731_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2017.11.041","volume":"819","author":"YS Zhang","year":"2018","unstructured":"Zhang YS, Li JD, Yan C (2018) An update on vinpocetine: new discoveries and clinical implications. Eur J Pharmacol 819:30\u201334. https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.041","journal-title":"Eur J Pharmacol"},{"issue":"2\u20134","key":"1731_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S1740925X12000129","volume":"7","author":"YY Zhao","year":"2011","unstructured":"Zhao YY, Yu JZ, Li QY, Ma CG, Lu CZ, Xiao BG (2011) TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation. Neuron Glia Biol 7(2\u20134):187\u2013197. https:\/\/doi.org\/10.1017\/S1740925X12000129","journal-title":"Neuron Glia Biol"},{"key":"1731_CR59","doi-asserted-by":"publisher","unstructured":"Zhong H, Li X, Zhou S, Jiang P, Liu X, Ouyang M, Nie Y, Chen X, Zhang L, Liu Y, Tao T, Tang J (2020) Interplay between RAGE and TLR4 regulates HMGB1-induced inflammation by promoting cell surface expression of RAGE and TLR4. J Immunol 205(3):767\u2013775 https:\/\/doi.org\/10.4049\/jimmunol.1900860","DOI":"10.4049\/jimmunol.1900860"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-024-01731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-024-01731-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-024-01731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T18:05:54Z","timestamp":1722621954000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-024-01731-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1731"],"URL":"https:\/\/doi.org\/10.1186\/s13568-024-01731-2","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental protocol was permitted by Research Ethics Committee, Faculty of Pharmacy, Delta University for Science and Technology (ethical approval number: FPDU11\/2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"89"}}